TABLE 6.
Typeabilities and DIs of RAPD analysis with primer 1254 or primer 1281 and REP-PCR with data from selected studies
| Technique | Authors (reference no.) | No. of unrelated patients | Typeabilitya | No. of typesb | DI |
|---|---|---|---|---|---|
| RAPD analysis with primer 1254 | Akopyanz et al. (3) | 64 | 64/64 | 64 | 1 |
| Dzierzanowska et al. (16) | 40 | 40/40 | 40 | 1 | |
| Schütze et al. (59) | 18 | 18/18 | 18 | 1 | |
| Weel et al. (75) | 20 | 20/20 | 20 | 1 | |
| Burucoa et al. (this study) | 40 | 40/40 | 38 | 0.99 | |
| Pooled results | 182/182 (100) | 1 | |||
| RAPD analysis with primer 1281 | Akopyanz et al. (3) | 64 | 64/64 | 64 | 1 |
| Dzierzanowska et al. (16) | 40 | 40/40 | 40 | 1 | |
| Jorgensen et al. (32) | 17 | 17/17 | 17 | 1 | |
| Wada et al. (73) | 16 | 16/16 | 16 | 1 | |
| Weel et al. (75) | 20 | 20/20 | 20 | 1 | |
| Burucoa (this study) | 40 | 40/40 | 40 | 1 | |
| Pooled results | 197/197 (100) | 1 | |||
| REP-PCR | Go et al. (25) | 70 | 70/70 | 68 | 0.99 |
| Dore et al. (13) | 12 | 12/12 | 11 | 0.98 | |
| Van Doorn et al. (72) | 32 | 32/32 | 31 | 0.99 | |
| Pooled results | 114/114 (100) | 0.99 |